DMD and MS partnerships for 1102 and another one for Acromegaly/1103 would obviously put ANP right up there as a takeover target for big pharma. Goolsbee has been bought on board to fastrack these agreements, he clearly has the credentials and contacts to make this happen. Eagerly awaiting a positive outcome... good luck to all holders...
ANP Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)